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Background: Laparoscopic sleeve gastrectomy (LSG) is increasingly popular due to its efficiency in reducing excess
weight, however little is known about the nutritional status in patients after surgery.
Purpose: To investigate how LSG affects energy intake, nutritional status and body weight one year after surgery.
Methods: A total of 150 patients (116 women) were enrolled in the study. Data on body weight, waist
circumference and blood samples were registered preoperatively and after surgery. Food intake was reported 3 and
12 months postoperatively.
Results: The preoperative median BMI was 44.3 (inter quartile range 41.4-47.1), and was significantly reduced to
35.4 (32.6-38.6) after 3 months and further reduced to 30.5 (27.4-33.8) 12 months after surgery (p < 0.05). The
median post surgery daily energy intake was significantly increased from 2971 (1982–3687) kJ after three months to
3840 (3046–4625) kJ twelve months postoperatively. One year after surgery, serum levels of folate, cobalamin, PTH
and HDL cholesterol were significantly increased, whereas calcium, albumin, haemoglobin, creatinine, uric acid, CRP,
glucose, insulin, insulin c-peptide, HOMA-IR, HbA1c and triacylglycerol were significantly decreased. Serum levels of
vitamins E and D were unchanged after one year. The prevalence of patients with medically regulated type 2
diabetes was significantly reduced one year post surgery however no changes were seen in the prevalence of
patients taking lipid lowering drugs or thyroxin.
Conclusion: Based on the data obtained 12 months after surgery, LSG appears to be an effective treatment of
morbid obesity without worsening the nutritional status despite the very low energy intake.
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The prevalence of obesity has increased in recent
decades, and obesity is now one of the leading public
health concerns on a worldwide scale. Obesity causes or
exacerbates many health problems, both independently
and in association with other diseases. In particular,
obesity is associated with the development of diabetes
mellitus type 2, coronary heart disease, an increased
incidence of certain forms of cancer, respiratory compli-
cations and osteoarthritis (Kopelman 2000).* Correspondence: oddrun.gudbrandsen@k1.uib.no
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in any medium, provided the original work is pDuring laparoscopic sleeve gastrectomy (LSG), about
90% of the stomach is surgically removed by vertical re-
section of the major side, including most of the fundus.
The simplicity of the LSG surgical procedure, the low oc-
currence of complications, and the efficiency of reducing
excess weight have made this restrictive procedure a
popular choice for weight reducing surgery (Aurora et al.
2011; Nocca et al. 2008; Bohdjalian et al. 2010; Gluck et al.
2011; Eid et al. 2012). After LSG, the amount of food
eaten is drastically reduced, potentially leading to nutri-
tional deficiencies.
Very little is known about the nutritional status in
patients after LSG, however, a few reports suggests that
LSG results in fewer nutritional deficiencies compared to
roux-en-Y gastric bypass (Toh et al. 2009; Gehrer et al.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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how LSG affects energy intake, weight loss and nutritional
status 3 and 12 months after surgery.
Methods
Patients submitted for LSG at Voss Hospital (Hordaland
County, Norway) between September 2008 and May 2010
were included in the present study. This study was
conducted according to the guidelines laid down in the
Declaration of Helsinki and all procedures involving
patients were approved by the Voss Hospital board as part
of a quality assurance project. Thus, this paper is based on
retrospective data, i.e. information and results that were
collected routinely from patients in the clinic. Written
informed consent was obtained from all patients. Partici-
pants were morbidly obese patients aged 18–60 years with
BMI ≥ 40, or BMI ≥ 35 with comorbidities such as dia-
betes mellitus type 2 (DM2), sleep apnoea, or hyperten-
sion. The preoperative population included 150 patients
(116 women).
Examinations were conducted 2–4 months prior to sur-
gery, and 3 and 12 months after surgery. Weight, height
and waist circumference were measured and fasting blood
samples were drawn at all visits. All patients were seen by
a dietician for routine dietary assessment and counselling
at all study visits.
The preoperative protocol involved a 4.2 MJ/day
(1000 kcal) diet supplemented with vitamins and long
chain omega-3 fatty acids for the last 2 months preopera-
tively with the purpose for the patients to lose weight (5–
10 kg), reduce fatty liver, and to decrease the risk of com-
plications associated with surgery (Benotti et al. 2009).
The patients were given recipes for suggestions on how to
prepare all meals (breakfast, lunch, dinner, evening meal
and fruits between meals), and were instructed to drink
1.5 L of water, sugar free lemonade, coffee, tea or bouillon
daily, and to stop smoking.
During the LSG procedure, a narrow gastric tube was
constructed along the minor side of the stomach, around
an intragastric 32-French bougie, giving the patients a
stomach volume of about 100 mL. A methylene blue
test was performed peroperatively to exclude staple-line
leakage. An x-ray contrast study was performed on the
second postoperative day, and oral fluids were allowed
when no leakage was demonstrated.
Postoperatively, patients were recommended to only
drink clear fluids (water, bouillon, or ProvideXtra from
Fresenius Kabi, Norway) for the first 3 days. On days
3–21 the patients follow a liquid diet with two protein
rich nutritional supplements and fluids mixed with
Resource Meritene (Nestle Nutrition, Norway). After
3 weeks, the patients were advised to eat mashed food
for one week and then gradually to start eating small
portions of protein rich food. Patients were given SomacControl (Takeda Nycomed), 20 mg/day for 100 days
postoperatively as acid reducing medication. The
patients were instructed to take supplements of multivi-
tamins (5 ug vitamin D/day, Vitamineral, Vitaplex), long
chain omega-3 fatty acids containing vitamin D (10 ug
vitamin D/day, Møllers Dobbel, Møllers) and calcium
citrate (500 mg calcium/day, Solaray Calcium Citrate,
Solaray).
Analyses of serum and blood samples
Vitamins, minerals, lipids and proteins levels were mea-
sured in serum samples, and hemoglobin and HbA1c
(glycated hemoglobin A1c) was measured in whole blood
added EDTA, performed by routine methods at the
Hormone Laboratory at Haukeland University Hospital
(Bergen, Norway) and at the Laboratory at Voss Hospital
(Voss, Norway). The insulin sensitivity (HOMA-IR)
(Matthews et al. 1985) was calculated from fasting
plasma glucose and insulin concentrations as glucose
[mmol/L] × insulin [mU/L] divided by 22.5.
Estimation of energy intake
Twenty-four hour recall interviews were conducted 3 and
12 months postoperatively to estimate the patients’ energy
intake. Calculations were performed using “Mat på Data”
version 5.1 (The Norwegian Food Safety Authority, the
Directorate for Health and the Department of Nutrition at
the University of Oslo).
Statistical analysis
Analysis of data was performed using PASW 19.0 soft-
ware (IBM Corporation, NY), with statistical signifi-
cance set at p < 0.05. The distribution of the data was
tested using Q-Q-plots, and since most data were non-
parametric distributed, differences in the nutritional pa-
rameters of the patients before and after surgery were
investigated using Wilcoxon Signed Ranks Test for non-
parametric distributions. McNemar Test was used to
compare the prevalence of abnormal and normal levels
before and after surgery, using reference values according
to the Hormone Laboratory at Haukeland University
Hospital (Bergen, Norway) and the Laboratory at Voss
Hospital (Voss, Norway). Correlation between vitamin D
and PTH was assessed by using Spearman's rho test.
Results
One-hundred and fifty patients (116 women) submitted
for LSG were enrolled in the study, with a median age of
43 years (intequartile range 34–51) (Table 1). Preopera-
tive bodyweight, BMI, percent excess body weight and
waist circumference (WC) is presented in Table 1. Of
these 150 patients, 139 patients (107 women) completed
the examination 3 months post surgery, and 125 patients
Table 1 Preoperative patient characteristics
Median Interquartile range
Men/women 34/116
Age (y) 1 43 34–51
Bodyweight (kg) 1 126.0 115.3–139.8
BMI (kg/m2) 1 44.3 41.4–47.7
Excess body weight (%)1 43.6 39.5–47.6
1Values as median (interquartile range).
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surgery.
The preoperative median BMI and WC for all patients
were significantly reduced after three months and further
reduced after twelve months (Table 2). Correspondingly,
the percent excess weight loss (%EWL) after surgery was
increased from 3 to 12 months post surgery. Estimation of
energy intake from 24 h recall interviews show that the
daily energy intake was very low after 3 months (2971 kJ,
or 710 kcal) but was significantly increased 12 months
postoperatively (3840 kJ, or 918 kcal). No data was avai-
lable for energy intake before surgery.
The median serum level of calcium was decreased after
12 months when compared to baseline (Table 3). No
change was seen in the prevalence of patients with
calcium level in the normal reference range when pre and
post surgery levels were compared. The serum folate and
cobalamin (vitamin B12) levels were increased, whereas
no changes were seen in levels of vitamins E and D, and
1,25-dihydroxy vitamin D, after one year (Table 3). The
prevalence of patients with folate below reference range
was significantly decreased from pre surgery to 12 months
post surgery, whereas no changes were seen in the preva-
lence of patients with vitamin levels in the normal
reference range for cobalamin, vitamin E, vitamin D and
1,25-dihydroxy vitamin D.
The serum albumin level was significantly decreased
after 3 months and stayed decreased after 12 months,Table 2 BMI, waist circumference, excess body weight loss an
after LSG
Preoperative 3 mo
(N = 150)
Median Interquartile range Median
BMI, kg/m2 44.3 41.4–47.1 35.4*
WC1, cm 131 123–138 112*
EWL2, % 0 45.7
EI 3, kJ/day NA 2971
1N = 138 preoperatively, N = 105 three months postoperatively, N = 118 twelve mon
2based on excess weight as starting at BMI > 25 (Almogy et al. 2004).
3N = 107 three months postoperatively, N = 120 twelve months postoperatively.
Wilcoxon Signed-Rank Test for pair wise comparison was used to investigate chang
*significantly different from preoperatively (p < 0.001).
**significantly different from 3 months postoperatively (p < 0.001).
WC waist circumference, EWL excess body weight loss, EI energy intake, NA not avawith no change in the distribution of normal and abnor-
mal values post surgery (Table 4). Haemoglobin and
creatinine serum levels were decreased after 3 months,
and further decreased after 12 months. The prevalence
of haemoglobin levels below normal range was increased
after three months but was comparable to pre surgery
values after 12 months, whereas no change in prevalence
of normal levels was seen for creatinine. Uric acid level
was decreased after 12 months concomitant with marked
reduction in the prevalence of patients with uric acid
levels above reference range. The median PTH level was
increased after 12 months, but the prevalence of patients
with PTH levels in the normal reference range was
unchanged. The CRP serum level and the prevalence of
abnormally high CRP levels were reduced after 3 months,
and both were further reduced after 12 months.
The median levels of fasting glucose, insulin, insulin
c-peptide, HOMA-IR and HbA1c levels were signifi-
cantly reduced after 12 months (Table 5). The preva-
lence of patients with elevated fasting glucose level was
significantly decreased and there was a decreased pre-
valence of patients with insulin in the normal range
whereas prevalence of insulin c-peptide in normal range
was unchanged. Also, a significant increase was seen in
the number of patients with HOMA-IR below 2 and of
patients with HbA1c level in the normal range.
No change was seen in levels or prevalence of abnor-
mal of total cholesterol level in patients one year after
surgery. However, the HDL cholesterol level was signifi-
cantly increased and triacylglycerol level was significantly
decreased after one year, whereas the prevalences of ab-
normal levels of both HDL cholesterol and triacylglycerol
were significantly decreased.
Only one patient with type 1 diabetes was enrolled in
the study, and this patient did not complete the 12 month
postoperative visit (Table 6). A significant reduction in the
use of antidiabetics was seen 12 months after surgery, and
concomitantly there was a significantly lower prevalenced energy intake preoperatively and 3 and 12 months
nths postoperative 12 months postoperative
(N = 139) (N = 125)
Interquartile range Median Interquartile range
32.6–38.6 30.5*,** 27.4–33.8
105–121 100*,** 94–108
38.1–55.6 72.1** 58.5–86.7
1982–3687 3840** 3046–4625
ths postoperatively.
es over time.
ilable.
Table 3 Serum concentrations and prevalence$ (under/in/above reference range) of calcium and vitamins
preoperatively and 12 months after LSG
Preoperative (N = 150) 12 months postoperative (N = 125)
Median Inter quartile range Prevalence (%) Median Inter quartile range Prevalence (%)
Calcium, mmol/L 2.36 2.29–2.41 5/92/3 2.33* 2.27–2.40 4/95/1
Folate1, nmol/L 11.3 8.2–15.8 23/77 16.0** 10.7–23.0 8/92†
Cobalamin , pmol/L 265 202–323 16/82/2 278* 209–421 8/86/6
Vitamin E2, umol/L 23.8 20.3–28.7 3/91/6 23.7 19.9–27.7 1/97/2
25-OH-vitamin D3, pmol/L 50.1 36.3–65.0 47/52/1 50.0 35.3–68.9 49/51/0
1,25-di-OH-vitamin D4 84 67–104 8/89/3 84 68–102 3/96/1
1N = 119 twelve months postoperatively, 2 N = 120 twelve months postoperatively, 3 N = 117 twelve months postoperatively, 4 N = 141 preoperatively, N = 111
twelve months postoperatively.
$Reference ranges used: Calcium 2.20-2.55 mmol/L; Folate > 8 nmol/L; Cobalamin 175–700 pmol/L; Vitamin E 11.6-40.0 umol/L; 25-hydroxyvitamin D 50–150 pmol/
L; 1,25-dihydroxy-vitamin D 50–150 pmol/L.
Wilcoxon Signed-Rank Test for pair wise comparison was used to investigate changes over time.
*significantly different from preoperatively (p < 0.05).
**significantly different from preoperatively (p < 0.001).
McNemar Test was used to compare the prevalence of values below normal reference range between pre and post surgery values.
†significantly different from preoperatively (p < 0.005).
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changes were seen in the prevalence of patients taking
lipid lowering drugs or thyroxin.
Discussion
The preoperative and 3 and 12 months postoperative
nutritional status and weight reduction were investigated
in 150 patients submitted for LSG surgery. As antici-
pated, BMI was significantly reduced 3 and 12 months
postoperatively. The %EWL 12 months post surgery was
reduced by 72.1, which is comparable to findingsTable 4 Serum concentrations and prevalence$ (under/in/abo
uric acid, PTH and CRP preoperatively and 3 and 12 months a
Preoperative (N = 150) 3 months
Median Inter quartile
range
Prevalence
(%)
Median In
Albumin1, g/L 44 43–46 1/78/21 43**
Haemoglobin,
g/dL
14.1 13.4–14.9 1/98/1 13.9*
Creatinine,
umol/L
65 57–72 6/91/3 63*
Uric acid, umol/L 354 305–421 0/99/51
PTH, pmol/L 4.1 3.0–6.1 2/80/18
CRP2, mg/L 6.0 4.0–11.0 37/63 4.0*
1N = 105 three months postoperatively, 2 N = 142 preoperatively, N = 105 three mon
$Reference ranges used: Albumin 18–39 yr: 36–48 g/L, 40–69 yr: 36–45 g/L; Hemog
umol/L, M:60–105 umol/L; Uric acid F < 50 yr: 155–350 umol/L, F > 50 yr: 155–400 u
Wilcoxon Signed-Rank Test for pair wise comparison was used to investigate chang
*significantly different from preoperatively (p < 0.05).
**significantly different from preoperatively (p < 0.001).
***significantly different from 3 months postoperatively (p < 0.05).
****significantly different from 3 months postoperatively (p < 0.001).
NA not available.
McNemar Test was used to compare the prevalence of values below normal referen
†significantly different from preoperatively (p < 0.005).
‡ significantly different from 3 months postoperatively (p < 0.005).reported by others for patients with similar pre surgery
BMI (Brethauer et al. 2009). Correspondingly, WC was
significantly reduced after surgery, although the mean
WC one year after surgery for 78% of our patients was
still above the action level by WHO set at ≥102 cm for
men and ≥88 cm for women (WHO 1997).
The median energy intake 3 months after surgery was
very low (2971 kJ/day), but was significantly increased
after 12 months (3840 kJ/day), which is an important
finding as very little is known about the caloric intake
after LSG. Our findings are comparable to findings in ave reference range) of albumin, haemoglobin, creatinine,
fter LSG
postoperative (N = 139) 12 months postoperative (N = 125)
ter quartile
range
Prevalence
(%)
Median Inter quartile
range
Prevalence
(%)
41–45 2/83/15 43** 42–45 0/91/9
13.0–14.7 7/89/4† 13.7**,*** 13.0–14.4 5/94/1
56–70 4/95/1 60**,**** 55–66 10/89/1
NA 284** 248–340 1/92/7†
NA 5.0* 3.5–6.7 2/77/21
4.0–8.0 57/43 † 4.0**,**** 4.0–4.0 90/10†‡
ths postoperatively.
lobin F ≥ 18 yr: 11.7-15.3 g/dL, M ≥ 18 yr: 13.4-17.0 g/dL; Creatinine F: 45–92
mol/L, M:230–480 umol/L; PTH 1.3-6.8 pmol/L; CRP <5 mg/L.
es over time.
ce range between pre and post surgery values.
Table 5 Circulating levels and prevalence$ (under/in/above reference range) of glucose, insulin, HOMA-IR, insulin c-
peptide, lipids, and HbA1c preoperatively and 12 months after LSG
Preoperative 12 months postoperative
(N = 150) (N = 125)
Median Inter quartile range Prevalence (%) Median Inter quartile range Prevalence (%)
Glucose1, mmol/L 5.5 5.2–6.0 1/76/23 4.9** 4.7–5.3 1/92/7†
Insulin2, mU/L 9.0 6.1–13.7 24/74/2 3.3* 2.0–6.7 73/27/0†
Insulin c-peptide3, nmol/L 0.94 0.69–1.18 3/92/5 0.61* 0.51–0.84 10/90/0
HOMA-IRA4 2.3 1.5–3.4 39/42/19 0.7* 0.5–1.4 85/12/3†
HbA1cB5, % 5.7 5.4–6.1 0/83/17 5.2* 5.0–5.5 0/96/4†
Total cholesterol6, mmol/L 5.0 4.4–5.8 6/84/10 5.0 4.4–5.6 2/95/3
HDL cholesterol7 , mmol/L 0.9 0.8–1.1 47/53/0 1.5* 1.3–1.7 2/98/0†
Triacylglycerol, mmol/L 1.97 1.31–2.61 1/75/24 0.95* 0.75–1.33 1/98/1†
1N = 137 preoperatively, 2 N = 145 preoperatively, 3 N = 146 preoperatively, 4 N = 135 preoperatively, 5 N = 133 preoperatively.
6N = 121 twelve months postoperatively, 7 N = 131 preoperatively.
$Reference ranges used: Glucose 4.0-6.0 mmol/L; Insulin 6.0-27.0 mU/L; Insulin c-peptide 0.4-1.7 nmol/L; HOMA-IR <2 nmol as normal value, ≥ 2 nmol/L is
pathological, > 4 reflecting the pre-diabetic stage; HbA1c 4.0-6.4%; Total cholesterol 18–29 yr: 2.9-6.1 mmol/L, 30–49 yr:3.3-6.9 mmol/L , ≥50 yr: 3.9-7.8 mmol/L;
HDL cholesterol F: 1.0-2.7 mmol/L, M:0.8-2.1 mmol/L; Triacylglycerol 0.45-2.60 mmol/L.
Wilcoxon Signed-Rank Test for pair wise comparison was used to investigate changes over time.
*significantly different from preoperatively (p < 0.001).
NA not available.
AHomeostasis model assessment – insulin resistance, prevalence shown as normal/pathological/pre-diabetic stage.
BGlycated hemoglobin A1c.
McNemar Test was used to compare the prevalence of values below normal reference range between pre and post surgery values.
†significantly different from preoperatively (p < 0.005).
‡significantly different from preoperatively (p < 0.05).
Gjessing et al. SpringerPlus 2013, 2:352 Page 5 of 7
http://www.springerplus.com/content/2/1/352small study (N = 21) reporting a median intake of
3266 kJ/day three months after longitudinal gastrec-
tomy (Almogy et al. 2004). The increased energy intake
over time in the present study may be explained by an
improved food tolerance (Overs et al. 2012), intake of
more energy dense food and probably also a certain
moderate widening of the gastric tube.
The low energy intake the first years post surgery is
challenging for the LSG patients as they need both a
detailed dietary plan and dietary supplements to achieveTable 6 Prevalence of diabetics and use of lipid lowering
drugs or thyroxin preoperatively and 12 months after
LSG
Preoperative 12 months
postoperative
Type 1 diabetes 1% $
Type 2 diabetes, taking insulin 1% 2%
Type 2 diabetes, medicated 14% 1%†
Type 2 diabetes, dietary
regulated
1% 3%
No diabetes 83% 94%†
Lipid lowering drugs 20% 13%
Thyroxin users 14% 15%
McNemar Test was used to compare the prevalence of values below normal
reference range between pre and post surgery values.
$One patient with type 1 diabetes was enrolled in the study, and this patient
did not complete the 12 month postoperative visit.
†significantly different from preoperatively (p < 0.05).sufficient intake of macro and micro nutrients, since it is
difficult to meet the daily requirements of vitamins and
minerals with a daily energy intake below 8.4 MJ (FAO/
WHO 2001). Also, the removal of most of the fundus and
hence the reduction in parietal cells, in addition to nausea,
vomiting and food intolerance experienced by some put
LSG patients at high risk for nutrient deficiencies. It has
been suggested that LSG has little impact on macronu-
trient deficiency since the procedure is restrictive and
therefore does not alter the absorption in the small intes-
tine (Baltasar et al. 2005). However, after LSG the stomach
contents may empty more rapidly into the small intestine
(Melissas et al. 2007), which in turn may reduce the bio-
availability and absorption of nutrients. Although the
median albumin level was decreased, the serum albumin
level was normal in the majority of our patients both pre-
operatively and postoperatively, and thus one can assume
that in general the patients had an overall sufficient pro-
tein intake after one year, which is in line with findings by
others (Damms-Machado et al. 2012; Hamoui et al. 2006).
Generally, LSG is believed not to cause fat malabsorp-
tion and thus the absorption of fat soluble vitamins should
not be affected. Vitamin E deficiency was observed in four
patients before and in only one patient one year after sur-
gery, and median levels were similar at these time points.
The prevalence of patients with vitamin D deficiency
was high (47%) possibly caused by reduced bioavailabi-
lity of vitamin D due to sequestration by adipose tissue
Gjessing et al. SpringerPlus 2013, 2:352 Page 6 of 7
http://www.springerplus.com/content/2/1/352(Wortsman et al. 2000). However, neither the median
vitamin D level nor the prevalence of patients with vita-
min D within the reference range were changed as pa-
tients lost weight. The patients were advised to take
vitamin D supplements, but due to the high prevalence
of vitamin D deficiency one can assume a low com-
pliance or low bioavailability as has been observed by
others after LSG (Capoccia et al. 2012). It is essential
that the vitamin D level is within the normal range for
sufficient intestinal calcium uptake, and a lack of vitamin
D will lead to a negative calcium balance and thus change
bone metabolism, and may cause a compensatory rise in
PTH to promote bone resorption (Aarts et al. 2011).
Hyperparathyroidism has been observed in a large propor-
tion (25-48%) of morbidly obese subjects (Hamoui et al.
2004; Carlin et al. 2006), and in the present study 18% of
the patients had PTH above normal range. After one year,
the median PTH level was significantly increased without
affecting the prevalence of patients with PTH above refer-
ence range, and the vitamin D and PTH levels were sig-
nificant inversely correlated (p < 0.01) both before and one
year after surgery. The reduction in calcium level, despite
the patients were instructed to take calcium supplements,
is probably caused by the reduced intake of calcium
containing food since these patients have a low energy
intake after surgery, whereas the unchanged vitamin D
level is likely due to patients taking supplements as food
itself is a less important source for this vitamin in this
population.
The absorption of cobalamin from food is dependent on
the presence of intrinsic factor and HCl, therefore the
resection of fundus may result in cobalamin deficiency
postoperatively if patients are not treated with oral supple-
mentations or injections of cobalamin (Capoccia et al.
2012). Bariatric patients struggle with the digestion of pro-
tein rich food in particular red meat (Elliot 2003) which is
a good source of cobalamin, and the protein intake is
reported to be below the recommended level for a high
proportion of patients after LSG (Andreu et al. 2010).
Despite that, an increased cobalamin level was observed
one year after surgery, possibly due to patients' use of
cobalamin supplements or injections as advised by health
personnel after LSG, however the prevalence of abnormal
cobalamin levels was not significantly changed. This is in
contrast to findings by others (Hakeam et al. 2009)
reporting an increased prevalence of low cobalamin levels
one year after LSG. Folate deficiency is not common after
LSG, since this vitamin can be absorbed throughout the
intestine, and therefore the observed low folate level post
surgery is probably a result of low intake of food rich in
this vitamin, such as legumes and green leafy vegetables,
and not due to reduced intestinal uptake. A significant de-
crease in the prevalence of abnormal folate level from be-
fore surgery was observed in the present study, and folatedeficiency was present in only 8% of the patients
12 months after surgery which is comparable with fin-
dings by others (Hakeam et al. 2009).
Obese patients usually have a chronic low-grade in-
flammatory condition, and this may affect many of the
biochemical and hormonal processes in the body, and it
has been have shown that LSG may improve the im-
mune status (Hakeam et al. 2009; Esposito et al. 2003).
Before surgery, about one third of our patients had
elevated CRP levels, and one year after surgery this
prevalence was markedly reduced to 10%, which is line
with finding by others (Hakeam et al. 2009). Concomi-
tant with lower CRP level, the reduced serum uric acid
level also suggests an improvement of the inflammatory
status (Gagliardi et al. 2009) in these patients.
Several studies confirm the efficiency of LSG in treat-
ment of diabetes mellitus type 2 in morbidly obese patients
(Rosenthal et al. 2009; Lee et al. 2010). One year after
LSG, the glycemic control was significantly improved, with
lower fasting glucose, insulin, insulin c-peptide, HOMA-IR
and HbA1c and increased prevalence of patients within
the normal range of these parameters except for insulin
c-peptide, probably as a result of weight loss. Concomi-
tant with this, a significant reduction in the number of
patients with medically regulated diabetes and lower
prevalence of type 2 diabetes were seen 12 months after
surgery.
As an indirect measure of the improved nutritional
status, and probably as a result of weight loss in the
patients, the circulating levels of HDL cholesterol was
significantly increased and that of triacylglycerol was sig-
nificantly decreased, which is in line with findings by
others (Benaiges et al. 2012). All patients had HDL levels
above of 0.9 mmol/L one year after surgery, which is the
threshold level defined by WHO (WHO 1999) for HDL
cholesterol for metabolic syndrome, thus these findings
suggests that our patients had a reduced risk of develo-
ping this syndrome one year after surgery.
There are some limitations to this study. First, not all
patients completed medical examinations after 3 or
12 months, and we have no information about why these
did not complete the protocol. Second, obese patients are
known to under-report their dietary intake (Lissner et al.
2000) and therefore the estimated energy intake based on
the 24 h recall interviews may be lower than the actual
intake.
In conclusion, based on the data obtained 12 months
after surgery, LSG has significant effect on weight loss and
appears to be an effective treatment of morbid obesity,
probably mediated through low energy intake. Despite the
low energy intake, the patients' nutritional status did not
worsen one year after surgery. The long term effect on
weight loss, energy intake and nutritional status of the
LSG procedure should be further investigated.
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